...
首页> 外文期刊>Natural Product Radiance (NPR) >DPP-IV Inhibitors from natural sources: An alternative approach for treatment and management of diabetes
【24h】

DPP-IV Inhibitors from natural sources: An alternative approach for treatment and management of diabetes

机译:来自自然来源的DPP-IV抑制剂:一种糖尿病治疗和管理的替代方法

获取原文
           

摘要

Diabetes is a chronic metabolic disorder present in almost all countries. According to WHO, T2DM is the World’s fifth leading cause of death. Treatment for T2DM depends on the incretin hormone (GLP-1 & GIP). GLP-1 plays a vital role in the body’s metabolism, such as insulin secretion but DPP-IV enzyme inactivates these incretin hormones. Therefore, it becomes important to identify DPP-IV inhibitors that act as prospective antidiabetic agents. Synthetic inhibitors like vildagliptin, sitagliptin, and saxagliptin are available in the market but they have some undesirable side effects. There are several natural plants as well as products that provide safe and effective medication against diabetes by DPP-IV enzyme inhibitory mechanism. This review summarizes recent advancement of DPP-IV inhibitors from medicinal plants and isolated phytoconstituents including alkaloids, flavonoids, terpenoids, phenol, and stilbenoids which are responsible for the DPP-IV inhibition.
机译:糖尿病是几乎所有国家的慢性代谢紊乱。根据谁,T2DM是世界第五届死亡原因。 T2DM的处理取决于Incetin激素(GLP-1和GIP)。 GLP-1在身体的新陈代谢中起着至关重要的作用,例如胰岛素分泌,但DPP-IV酶灭活这些增量蛋白激素。因此,鉴定充当前瞻性抗糖尿病药剂的DPP-IV抑制剂变得重要。像Vilyagliptin,SitaGliptin和Saxagliptin等合成抑制剂可在市场上获得,但它们具有一些不良副作用。通过DPP-IV酶抑制机制,有几种天然植物以及为糖尿病提供安全有效的药物。本综述总结了来自药用植物和分离的植物植物的DPP-IV抑制剂,包括生物碱,类黄酮,三萜类化合物,苯酚和斯蒂屈剂,其负责DPP-IV抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号